+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pazopanib"

Global Sarcoma Drugs Market by Indication (Angiosarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans), Drugs (Chemotherapy Drugs, Immunotherapy Drugs, Targeted Drug Therapy), Sales Channel, End-User - Forecast 2024-2030 - Product Thumbnail Image

Global Sarcoma Drugs Market by Indication (Angiosarcoma, Chondrosarcoma, Dermatofibrosarcoma Protuberans), Drugs (Chemotherapy Drugs, Immunotherapy Drugs, Targeted Drug Therapy), Sales Channel, End-User - Forecast 2024-2030

  • Report
  • March 2024
  • 195 Pages
  • Global
From
Kidney Cancer Drugs Global Market Report 2024 - Product Thumbnail Image

Kidney Cancer Drugs Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Renal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Renal Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 180 Pages
  • Global
From
Gastrointestinal Stromal Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Gastrointestinal Stromal Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
Global Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Global Oncology Drugs Market Size, Share & Industry Trends Analysis Report By Indication, By Drug Class Type (Targeted Therapy, Immunotherapy (Biologic Therapy), Chemotherapy and Hormonal Therapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • November 2023
  • 306 Pages
  • Global
From
Global Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030 - Product Thumbnail Image

Global Metastatic Cancer Drugs Market Size, Share & Industry Trends Analysis Report By Distribution Channel, By Indication, By Therapy (Targeted Therapy, Immunotherapy, Hormonal Therapy and Chemotherapy), By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • July 2023
  • 290 Pages
  • Global
From
Precision Cancer Therapeutics, 2022 - Product Thumbnail Image

Precision Cancer Therapeutics, 2022

  • Report
  • November 2022
  • 154 Pages
  • Global
From
Global Proto Oncogene Market & Clinical Pipeline Insight 2024 - Product Thumbnail Image

Global Proto Oncogene Market & Clinical Pipeline Insight 2024

  • Drug Pipelines
  • February 2018
  • 440 Pages
  • Global
From
Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026 - Product Thumbnail Image

Global Small Molecule Cancer Drug Market, Drug Price, Dosage & Clinical Trials Insight 2026

  • Report
  • June 2020
  • 753 Pages
  • Global
From
Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028) - Product Thumbnail Image

Middle East and Africa Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, COVID-19 Impact, and Forecasts (2023-2028)

  • Report
  • April 2023
  • 90 Pages
  • Middle East, Africa
From
North America Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025) - Product Thumbnail Image

North America Kidney Cancer Therapeutics & Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025)

  • Report
  • August 2020
  • 80 Pages
  • North America
From
Chondrosarcoma Market Insight, Epidemiology And Market Forecast - 2032 - Product Thumbnail Image

Chondrosarcoma Market Insight, Epidemiology And Market Forecast - 2032

  • Report
  • April 2023
  • 137 Pages
  • Global
From
Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030 - Product Thumbnail Image

Kidney Cancer/Renal Cell Carcinoma (RCC) Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2022 to 2030

  • Report
  • August 2022
  • 115 Pages
  • Global
From
Votrient (pazopanib; Novartis) Drug Overview 2019 - Product Thumbnail Image

Votrient (pazopanib; Novartis) Drug Overview 2019

  • Report
  • March 2019
  • 21 Pages
  • Global
Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020 - Product Thumbnail Image

Tyrosine Protein Kinase ITK/TSK - Pipeline Review, H1 2020

  • Drug Pipelines
  • February 2020
  • 66 Pages
  • Global
From
Pazopanib API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Thumbnail Image

Pazopanib API Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • February 2024
  • 118 Pages
  • Global
From
  • 17 Results (Page 1 of 1)
Loading Indicator

Pazopanib is an oncology drug used to treat certain types of cancer. It is a tyrosine kinase inhibitor, meaning it works by blocking the action of certain enzymes that are involved in the growth and spread of cancer cells. Pazopanib is used to treat advanced renal cell carcinoma, a type of kidney cancer, and advanced soft tissue sarcoma, a type of cancer that affects the connective tissues. It is also used to treat other types of cancer, such as ovarian cancer and thyroid cancer. Pazopanib is available in tablet form and is taken orally. It is usually taken once daily, with or without food. Common side effects of pazopanib include nausea, vomiting, diarrhea, fatigue, and hair loss. Some companies in the pazopanib market include GlaxoSmithKline, Novartis, and Pfizer. Show Less Read more